Drug ID: | NPD9443 |
Drug Name: | |
Molecular Formula: | C8H15NO4 |
Canonical SMILES: | O[C@@H]1[C@@H](O)CN2[C@@H]([C@H]1O)[C@@H](O)CC2 |
Standard InCHI: | InChI=1S/C8H15NO4/c10-4-1-2-9-3-5(11)7(12)8(13)6(4)9/h4-8,10-13H,1-3H2/t4-,5-,6+,7+,8+/m0/s1 |
Standard InCHIKey: | JDVVGAQPNNXQDW-TVNFTVLESA-N |
Max Developmental Stage: | Clinical (unspecified phase) |
Max Developmental Stage Source: | TTD |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
Tanimoto coefficient is calculated based on PubChem 881-bit substructure fingerprints.
High Similarity Level: Tc>=0.85; Intermediate Similarity Level: 0.7 <= Tc < 0.85; Remote Similarity Level: 0.65 <= Tc < 0.7
TTD | DIB000712 |
DrugBank | |
ChEMBL | |
IUPHAR/BPS | |
PharmaGKB | |
KEGG Drug | |
PubChem CID | |
ChEBI | |
CAS Number |
Molecular Weight | 189.10 |
ALogP | -2.3448 |
MLogP | 1.79 |
XLogP | -1.792 |
HDA | 5 |
HBD | 4 |
Rotatable Bonds | 4 |
TPSA | 84.16 |
RO5 Violation | 0 |